Atlas Trials

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine

Clinical trial NCT02868073 · COMPLETED

Trial details

NCT number
NCT02868073
Sponsor
Vaxart
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Norovirus Gastroenteritis
Start date
2016-07-29
Primary completion
2016-10-05
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.